DOCTOR Doctor introduction
-
院長 Miyuki Nagaba MIYUKI NAGABA
Subject in charge
Regenerative medicine, gynecology, cosmetic dermatology
Career
- 2001
- Graduated from Fujita Health University School of Medicine
- 2001
- Worked at Hiroshima University Hospital
- 2003
- Worked at Hiroshima General Hospital
- 2005
- Worked at Hiroshima Railway Hospital
- 2008
- Worked at Hiroshima HART Clinic
Qualifications/Licenses
Japanese Society of Obstetrics and Gynecology Specialist
-
Advisor Yoshito Niki YOSHIHITO NIKI
Subject in charge
Infectious Diseases
Career
- 1976
- Graduated from Kawasaki Medical School
- 1982
- Kawasaki Medical School, Department of Respiratory Medicine
- 1988
- New York City, New York State, USA
Study abroad at Memorial Sloan-Kettering Cancer Center
- 1990
- Lecturer, Department of Health and Medical Sciences, Respiratory Medicine, Kawasaki Medical School
- 2006
- Professor, Department of Clinical Infectious Diseases (Endowed Chair), Showa University School of Medicine
- 2017
- Specially Appointed Professor, Department of Internal Medicine, Clinical Infectious Diseases, Showa University School of Medicine
- 2024
- Professor Emeritus of Showa University, the name of the university will be changed to Showa Medical University in 2025
Conference presentations and papers
- 2010
- President of the 57th General Meeting of the Eastern Japan Branch of the Japanese Society of Chemotherapy
- 2013
- The 163rd Kanto Branch Meeting of the Japanese Society for Tuberculosis
President of the 203rd Kanto Joint Meeting of the Japanese Respiratory Society
- 2013
- President of the 57th General Meeting of the Japanese Society of Medical Mycology
- 2014
- Chairman of the 1st Tokyo Society for the Study of Intractable Infectious Diseases
- 2015
- 49th General Chairman of the Pseudomonas Aeruginosa Research Society
- 2015
- President of the 63rd General Meeting of the Japanese Society of Chemotherapy, etc.
Qualifications/Licenses
Honorary member of the Japanese Society of Internal Medicine
Honorary member of the Japanese Association of Infectious Diseases
Japanese Respiratory Society: Distinguished Member
Honorary member of the Japanese Society for Medical Mycology
Honorary member of the Japanese Society of Chemotherapy
Distinguished Member of the Japanese Society for Tuberculosis and Nontuberculous Mycobacterial Diseases
Japanese Society for Environmental Infection: Distinguished Member
-
Director of the Regenerative Medicine Department, Doctor of Medicine Takashi Kuroda YUTAKA KURODA
Subject in charge
Regenerative medicine, orthopedics
Career
- 1994
- Graduated from the Department of Economics, Faculty of Economics, Keio University
- 1999
- Graduated from St. Marianna University School of Medicine
- 1999
- Kyoto University Hospital
- 2001
- Resident at Kobe City Medical Center Central Hospital
- 2009
- Graduated from Kyoto University Graduate School of Medicine, Department of Orthopedic Surgery
- 2012
- Kyoto University Hospital, Department of Orthopedic Surgery, Assistant Professor
- 2015
- Assistant Professor, Department of Orthopedic Surgery, Kyoto University Hospital
- 2020
- Lecturer, Department of Orthopedic Surgery, Kyoto University Hospital
Conference presentations and papers
- 2010
- Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres. J Bone Miner Metab. 2010;28:606-616.
- 2015
- Modified Mostardi approach with ultra-high-molecular-weight polyethylene tape for total hip arthroplasty provides a good rate of union of osteotomized fragments. J Orthop Sci. 2015;20(4):633-641.
- 2016
- A pilot study of regenerative therapy using controlled release of rhFGF-2 for patients with precollapse osteonecrosis of the femoral head. Int Orthop.
2016; 40 (8): 1747-1754.
- 2019
- Clinical application of injectable growth factor for bone regeneration: A systematic review. Inflamm Regen. 2019;39:20.
- 2019
- Classification of osteonecrosis of the femoral head: Who should have surgery? Bone Joint Res. 2019;8:451-458.
- 2021
- Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial. Regen Med. 2021 Jun;16(6):535-548.
- 2024
- Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials. Expert Opin Investig Drugs. 2024 Apr;33(4):405-414.
Qualifications/Licenses
Affiliated academic societies:
Japanese Orthopaedic Association (Councillor), Japanese Hip Society (Councillor), Japanese Society for Regenerative Medicine, Japanese Society for Inflammation and Regenerative Medicine, Japanese Society for Artificial Joint Research, Chubu Disaster Orthopaedic Association, DDS Regenerative Medicine Study GroupIdiopathic osteonecrosis of the femoral head: Member of the Ministry of Health, Labor and Welfare's meeting and committee member for formulating treatment guidelines
Specialist of the Japanese Orthopaedic Association, designated doctor for intractable diseases
-
Shigeki Nagura Shigeki Nagara
Subject in charge
Regenerative medicine, orthopedics
Career
- 2003
- Graduated from the Department of Administration Engineering, Faculty of Science and Technology, Keio University
- 2009
- Graduated from St. Marianna University School of Medicine
- 2009
- St. Marianna University School of Medicine Yokohama City Western Hospital Early Clinical Worker
- 2011
- Joined the Department of Orthopedic Surgery at Keio University
- 2012
- Worked at tertiary emergency hospitals such as Shizuoka Red Cross Hospital, Hiratsuka Municipal Hospital, and Saiseikai Utsunomiya Hospital, as well as other hospitals affiliated with the medical department (experienced trauma and upper limb disorders).
- 2025.7
- Appointed Director of Arakawa Nagura Orthopedic Clinic, Medical Corporation
Conference presentations and papers
- 2017
- A case of bone defect caused by infection after ORIF of peri-implant fracture treated with Masquelet reconstruction
(43rd Annual Meeting of the Japanese Orthopaedic Trauma Association)
- 2018
- Seven cases of bone union after bone reconstruction using the Masquelete technique
(44th Annual Meeting of the Japanese Orthopaedic Trauma Association)
- 2019
- Bridging external fixation combined with arthroscopic reduction is effective for intra-articular comminuted distal radius fragments with palmar marginal bone fragments
(Journal of the Japanese Society for Surgery of the Hand, Vol. 35, No. 5)
- 2020
- A comparison of Splint Versus Pinnning the Distal Interphalangeal Joint for Acute Closed tendinous Mallet fingers (J Hand Surg Asian Vol 25(2))
- 2020
- Two-stage fixation is effective in postoperative treatment of fresh bony mallet cases
(63rd Annual Meeting of the Japanese Society for Surgery of the Hand)
- 2022
- Current status and future challenges of osteoporosis in upper limb fracture cases at our hospital
(65rd Annual Meeting of the Japanese Society for Surgery of the Hand)
Qualifications/Licenses
Japanese Orthopaedic Association (Japanese Specialist Organization Orthopaedic Surgeon Specialist and Supervising Physician)
Japanese Society for Surgery of the Hand, Hand Surgery Specialist
Japanese Orthopaedic Association Certified Rheumatologist/Rehabilitation Doctor
Japanese Rehabilitation Association Certified Clinician
-
Beauty department manager Yoshino Muraishi YOSHIYA MURAISHI
Subject in charge
Regenerative medicine, cosmetic dermatology
Career
- 1987
- Graduated from Shinshu University School of Medicine
- 1987
- Department of Neurosurgery, University of Tokyo Hospital
- 1988
- Department of Plastic Surgery, Juntendo University Hospital
- 1988
- Assistant Professor, Department of Plastic Surgery, Juntendo University School of Medicine
- 1993
- Chief Physician, Department of Plastic Surgery, Juntendo Izunagaoka Hospital
- 1996
- Assistant Professor, Department of Plastic Surgery, Juntendo University School of Medicine
- 1997
- Served as director of a major cosmetic surgery clinic
Qualifications/Licenses
Specialist certified by the Japanese Society of Plastic Surgery
Japan Society of Plastic and Reconstructive Surgery
-
Eriko Nemoto ERIKO NEMOTO
Subject in charge
Cosmetic dermatology
Career
- 2008
- Graduated from the Faculty of Medicine, Osaka Medical and Pharmaceutical University
- 2008
- Kinki Central Hospital, Public School Mutual Aid Association
- 2010
- Central Japan Railway Company Nagoya Central Hospital
- 2012
- Sakae Clinic Cosmetic Dermatology
- 2013
- Director of Ginza Solaria Clinic
- 2016
- Clinic Le GINZA Director
- 2023
- ALOOP CLINIC & LAB Vice Director
Qualifications/Licenses
Ministry of Health, Labor and Welfare Certified Anesthesiologist
-
Masaki Mukai MASAKI MUKAI
Subject in charge
Cosmetic dermatology, regenerative medicine, psychiatry and child psychiatry
Career
- 2020
- Graduated from Teikyo University School of Medicine
- 2022
- Nippon Medical School Tama Nagayama Hospital
- 2023
- Seibikai Tama Central Hospital
- 2024
- Tokyo Metropolitan Children's Medical Center, Child and Adolescent Psychiatry Department
Qualifications/Licenses
Affiliated academic society: Japanese Society of Psychiatry and Neurology
Clinic Le GINZA
5 features
Treating aging as a therapeutic target
New regenerative medicine
The aim is to scientifically measure and improve chronic inflammation, a treatable cause of ailments that have traditionally been attributed to aging (an approach to scientifically diagnosing and treating aging).
by specialists in each field
"Team medical care" system
Orthopedic, gynecological, and internal medicine doctors work together to create treatment plans optimized for each patient's condition.
Maximize the body's natural ability to recover
"Cell Revival®"
A unique three-step treatment that improves chronic inflammation and prepares the foundation for stem cell therapy
Based on scientific data
Effect verification
Inflammatory marker testing and EpiClock testing confirm improvement through data, not just feelings
Rest assured even after treatment
Long-term follow-up
Regular checkups and support for up to two years will help maintain and further improve the effectiveness of treatment.